Trademark: 90772551
Word
HANCHORBIO
Status
Registered
Status Code
700
Status Date
Tuesday, August 23, 2022
Serial Number
90772551
Registration Number
6824471
Registration Date
Tuesday, August 23, 2022
Mark Type
4000
Filing Date
Monday, June 14, 2021
Published for Opposition
Tuesday, June 7, 2022

Trademark Owner History
HanchorBio Inc. - Original Registrant

Classifications
5 Pharmaceutical products and medicines for the treatment of cancers or autoimmune diseases for human use; Reagents for medical diagnostics; Therapeutic reagents for promoting hair growth; Vaccines for human use; Pharmaceutical reagents for medical use, namely, to enhance immunity; Anti-cancer reagents and medicines; Image-forming reagents for medical diagnostics; Western medicines for treating cancers or autoimmune diseases; Chinese medicines for treating cancers or autoimmune diseases; Anti-viral reagents and medicines for treating cancers or autoimmune diseases; Biological reagents and medicines for medical therapeutic use for the treatment of cancers or autoimmune diseases; Protein reagents and medicines for medical therapeutic use for the treatment of cancers or autoimmune diseases; Chemical reagents and medicines for medical therapeutic use for the treatment of cancers or autoimmune diseases; Biological tissue culture reagents for medical therapeutic use for the treatment of cancers or autoimmune diseases; Testing chemicals for medical therapeutic use for the treatment of cancers or autoimmune diseases; Diagnostic reagents for medical therapeutic use; Biomarker diagnostic reagents for medical therapeutic use; Nutritional supplements; Biological reagents for veterinary use
35 retail and wholesale store services featuring pharmaceutical products; retail and wholesale store services featuring western medicines; retail and wholesale store services featuring Chinese medicines; retail and wholesale store services featuring nutritional supplements; retail and wholesale store services featuring medical equipment
42 Providing services for biomedical research and development, namely, producing biological medicines; Biological research; Bacteriological research; Providing experimental medicines sample testing and diagnostic services for others for clinical research purposes; Providing reagent sample testing and diagnostic services for others for clinical research purposes; Clinical testing of pharmaceutical medicines for others; Scientific research and analysis of experimental medicines or reagents; Medical research; Product research and development on behalf of other parties; Technical research in the field of pharmaceutical studies; Research for technological programs in the nature of biological drug design; Technical writing, namely, writing of technological documents; industrial analysis and research services; Rental of laboratory equipment for experiments; Service for scientific laboratories; Scientific research; Technological consultancy in the field of biological protein engineering; Scientific research in the field of biological/biomedical protein design and engineering; technical research in the field of biological/biomedical protein design and engineering

Trademark Events
Jan 3, 2023
Teas Change Of Correspondence Received
Jan 3, 2023
Teas Change Of Domestic Representatives Address
Jan 3, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 3, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Aug 23, 2022
Notice Of Registration Confirmation Emailed
Aug 23, 2022
Registered-Principal Register
Jun 14, 2022
Withdrawn From Issue - Petitions Office Request
Jun 8, 2022
Teas Delete 1(B) Basis Received
Jun 7, 2022
Official Gazette Publication Confirmation E-Mailed
Jun 7, 2022
Published For Opposition
May 18, 2022
Notification Of Notice Of Publication E-Mailed
May 3, 2022
Approved For Pub - Principal Register
Apr 7, 2022
Teas/Email Correspondence Entered
Apr 7, 2022
Correspondence Received In Law Office
Apr 4, 2022
Assigned To Lie
Mar 31, 2022
Teas Response To Office Action Received
Mar 8, 2022
Notification Of Non-Final Action E-Mailed
Mar 8, 2022
Non-Final Action E-Mailed
Mar 8, 2022
Non-Final Action Written
Mar 3, 2022
Assigned To Examiner
Sep 1, 2021
New Application Office Supplied Data Entered In Tram
Jun 17, 2021
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24